<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0187-5337</journal-id>
<journal-title><![CDATA[Perinatología y reproducción humana]]></journal-title>
<abbrev-journal-title><![CDATA[Perinatol. Reprod. Hum.]]></abbrev-journal-title>
<issn>0187-5337</issn>
<publisher>
<publisher-name><![CDATA[Instituto Nacional de Perinatología]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0187-53372024000300004</article-id>
<article-id pub-id-type="doi">10.24875/per.24000020</article-id>
<title-group>
<article-title xml:lang="en"><![CDATA[Findings in the use of the dual rapid test for detection of HIV and syphilis in pregnant women in Mexico]]></article-title>
<article-title xml:lang="es"><![CDATA[Hallazgos en la utilización de la prueba rápida dual para detección de VIH y sífilis en embarazadas en México]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Herrera-Medina]]></surname>
<given-names><![CDATA[Emilia F.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,National Institutes of Health, Ministry of Health Instituto Nacional de Perinatología Isidro Espinosa de los Reyes Department of Pediatric Follow-Up]]></institution>
<addr-line><![CDATA[Mexico City ]]></addr-line>
<country>Mexico</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2024</year>
</pub-date>
<volume>38</volume>
<numero>3</numero>
<fpage>92</fpage>
<lpage>100</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S0187-53372024000300004&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S0187-53372024000300004&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S0187-53372024000300004&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract Although dual rapid tests for HIV/Syphilis screening were introduced in our country in 2012, an evaluation of the use of these tests has not been carried out to date. The objective of the study was to know the progress in the use of the rapid dual test for the detection of HIV/Syphilis in the population of pregnant women in Mexico. A descriptive cross-sectional study was carried out to know the situation of the use of the test as a screening for pregnant women in the two main health institutions: the Secretary of Health in the states and the Mexican Social Security Institute ordinary regime for the year 2023. It was found that despite having sufficient dual tests in the states, the percentages of application of the test are less than 50% in most of them and the percentage of patients for whom it is confirmed their test when it is reactive for HIV/Syphilis is less than 20% in the case of the Secretary of Health. A more in-depth study is required to determine the causal agents.]]></p></abstract>
<abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen A pesar de que en nuestro país se introdujeron en el 2012 las pruebas rápidas duales para el tamizaje de VIH/Sífilis, no se ha realizado hasta el momento una evaluación de la utilización de estas pruebas. El objetivo del estudio fue conocer los avances en el uso de la prueba dual rápida para la detección de VIH/Sífilis en la población de mujeres embarazadas en México. Se realizó un estudio transversal descriptivo para conocer la situación de la utilización de la prueba como tamiz para las mujeres embarazadas de las dos principales instituciones de salud: la Secretaría de Salud en los estados y el Instituto Mexicano del Seguro Social, régimen ordinario para el año 2023. Se encontró que los porcentajes de aplicación de la prueba en los estados, a pesar de contar con las suficientes, son menores al 50% en la mayoría de ellos y el porcentaje de pacientes a los cuales se les confirma su prueba cuando resulta reactiva para VIH/Sífilis, es menor al 20% en el caso de la Secretaría de Salud. Se requiere realizar un estudio más profundo para determinar los agentes causales.]]></p></abstract>
<kwd-group>
<kwd lng="en"><![CDATA[Dual test]]></kwd>
<kwd lng="en"><![CDATA[Syphilis/HIV]]></kwd>
<kwd lng="en"><![CDATA[Screening]]></kwd>
<kwd lng="es"><![CDATA[Pruebas duales]]></kwd>
<kwd lng="es"><![CDATA[Sífilis/VIH]]></kwd>
<kwd lng="es"><![CDATA[Tamizaje]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="">
<collab>World Health Organization (WHO)</collab>
<source><![CDATA[The Dual Rapid Diagnosis Test for HIV Infection and Syphilis can be used as the First Test in Prenatal Care]]></source>
<year>2019</year>
<page-range>1-4</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Storey]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Seghers]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Pyne-Mercier]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Peeling]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Newman]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Taylor]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Syphilis diagnosis and treatment during antenatal care:the potential catalytic impact of the dual HIV and syphilis rapid diagnostic test]]></article-title>
<source><![CDATA[Lancet Glob Health]]></source>
<year>2019</year>
<volume>7</volume>
<page-range>1006-8</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Harriet]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Peeling]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Kamb]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Toskin]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Wi]]></surname>
<given-names><![CDATA[TE]]></given-names>
</name>
<name>
<surname><![CDATA[Taylor]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A systematic review and meta-analysis of studies evaluating the performance and operational characteristics of dual point-of-care test for HIV and Syphilis]]></article-title>
<source><![CDATA[Sex Transm Infect]]></source>
<year>2017</year>
<volume>93</volume>
<page-range>S3-15</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[Q]]></given-names>
</name>
<name>
<surname><![CDATA[Chan]]></surname>
<given-names><![CDATA[PL]]></given-names>
</name>
<name>
<surname><![CDATA[Newman]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Dou]]></surname>
<given-names><![CDATA[LI]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[XY]]></given-names>
</name>
<name>
<surname><![CDATA[Qiao]]></surname>
<given-names><![CDATA[YP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Acceptability and feasibility of dual HIV and syphilis point-of-care testing for early detection of infection among pregnant women in China:a prospective study]]></article-title>
<source><![CDATA[BMJ Open]]></source>
<year>2018</year>
<volume>8</volume>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kiarie]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Mishra]]></surname>
<given-names><![CDATA[CK]]></given-names>
</name>
<name>
<surname><![CDATA[Temmerman]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Newman]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Accelerating the dual elimination of mother-to-child transmission of syphilis and HIV;why now?]]></article-title>
<source><![CDATA[Int J Gynaecol Obstet]]></source>
<year>2015</year>
<volume>130</volume>
<page-range>S1-3</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Seña]]></surname>
<given-names><![CDATA[AC]]></given-names>
</name>
<name>
<surname><![CDATA[White]]></surname>
<given-names><![CDATA[BL]]></given-names>
</name>
<name>
<surname><![CDATA[Sparling]]></surname>
<given-names><![CDATA[PF]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Novel Treponema pallidum serologic tests. A paradigm shift in syphilis screening for the 21st century]]></article-title>
<source><![CDATA[Clin Infect Dis]]></source>
<year>2010</year>
<volume>51</volume>
<page-range>700-8</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="">
<collab>World Health Organization (WHO)</collab>
<source><![CDATA[Information Note on the Use of the Rapid Dual Diagnosis Test for HIV and Syphilis]]></source>
<year>2017</year>
<page-range>1-7</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Coreño]]></surname>
<given-names><![CDATA[MO]]></given-names>
</name>
<name>
<surname><![CDATA[Ocañan]]></surname>
<given-names><![CDATA[LR]]></given-names>
</name>
<name>
<surname><![CDATA[Espinoza de los Monteras]]></surname>
<given-names><![CDATA[JO]]></given-names>
</name>
<name>
<surname><![CDATA[Dorantes]]></surname>
<given-names><![CDATA[VM]]></given-names>
</name>
<name>
<surname><![CDATA[Ramírez]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Validez de una prueba rápida dual para detección de VIH/sífilis en tres delegaciones del Instituto Mexicano del Seguro Social (IMSS)]]></article-title>
<source><![CDATA[Perinatol Reprod Hum]]></source>
<year>2015</year>
<volume>29</volume>
<page-range>8-13</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Posadas-Robledo]]></surname>
<given-names><![CDATA[FJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Embarazo y VIH;indicación absoluta de césarea?]]></article-title>
<source><![CDATA[Ginecol Obstet Mex]]></source>
<year>2018</year>
<volume>86</volume>
<page-range>374-82</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="">
<collab>Centro Nacional Para la Prevención y el Control del VIH y el SIDA</collab>
<source><![CDATA[Guía Para la Detección del Virus de la Inmunodeficiencia Humana (VIH)]]></source>
<year>2018</year>
</nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="">
<collab>Secretaría de Salud Subsecretaría de Prevención y Promoción de la Salud, Dirección General de Epidemiología</collab>
<source><![CDATA[Manual de Procedimientos Estandarizados Para la Vigilancia Epidemiológica de Sífilis Congénita, México]]></source>
<year>2021</year>
</nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="">
<collab>Centro Nacional Para la Prevención y el Control del VIH y el SIDA</collab>
<source><![CDATA[Boletín de Atención Integral de las Personas que Viven con VIH]]></source>
<year>2023</year>
<page-range>1-5</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="">
<collab>Secretaria de Salud, Consejo de Salubridad General (CSG)</collab>
<source><![CDATA[Compendio Nacional de Insumos y Medicamentos, México]]></source>
<year>2023</year>
<page-range>871-2</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
